537 related articles for article (PubMed ID: 30030167)
1. Therapeutic effect of Imiquimod enhanced ALA-PDT on cutaneous squamous cell carcinoma.
Bhatta AK; Wang P; Keyal U; Zhao Z; Ji J; Zhu L; Wang X; Zhang G
Photodiagnosis Photodyn Ther; 2018 Sep; 23():273-280. PubMed ID: 30030167
[TBL] [Abstract][Full Text] [Related]
2. Interventions for cutaneous Bowen's disease.
Bath-Hextall FJ; Matin RN; Wilkinson D; Leonardi-Bee J
Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD007281. PubMed ID: 23794286
[TBL] [Abstract][Full Text] [Related]
3. Intraindividual, right-left comparison of topical 5-aminolevulinic acid photodynamic therapy vs. 5% imiquimod cream for actinic keratoses on the upper extremities.
Sotiriou E; Apalla Z; Maliamani F; Zaparas N; Panagiotidou D; Ioannides D
J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):1061-5. PubMed ID: 19470041
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial.
Arits AH; Mosterd K; Essers BA; Spoorenberg E; Sommer A; De Rooij MJ; van Pelt HP; Quaedvlieg PJ; Krekels GA; van Neer PA; Rijzewijk JJ; van Geest AJ; Steijlen PM; Nelemans PJ; Kelleners-Smeets NW
Lancet Oncol; 2013 Jun; 14(7):647-54. PubMed ID: 23683751
[TBL] [Abstract][Full Text] [Related]
5. The effect of C-X-C motif chemokine ligand 13 in cutaneous squamous cell carcinoma treated with aminolevulinic acid-photodynamic therapy.
Zhu L; Zhang G; Wang P; Zhang L; Ji J; Liu X; Zhou Z; Zhao J; Wang X
Photodiagnosis Photodyn Ther; 2019 Jun; 26():389-394. PubMed ID: 31022580
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of dendritic cells by DAMPs in ALA-PDT treated SCC tumor cells.
Wang X; Ji J; Zhang H; Fan Z; Zhang L; Shi L; Zhou F; Chen WR; Wang H; Wang X
Oncotarget; 2015 Dec; 6(42):44688-702. PubMed ID: 26625309
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic and immune effects of 5-aminolevulinic acid photodynamic therapy on UVB-induced squamous cell carcinomas in hairless mice.
Wang H; Li J; Lv T; Tu Q; Huang Z; Wang X
Exp Dermatol; 2013 May; 22(5):362-3. PubMed ID: 23614746
[TBL] [Abstract][Full Text] [Related]
8. A Clinical Trial Using Attrition Combined with 5-Aminolevulinic Acids Based Photodynamic Therapy in Treating Squamous Cell Carcinoma.
Peng J; Feng W; Luo X; Wang T; Xiang W; Dai Y; Zhu J; Zheng J
Med Sci Monit; 2017 Mar; 23():1347-1354. PubMed ID: 28314866
[TBL] [Abstract][Full Text] [Related]
9. CCL8 enhances sensitivity of cutaneous squamous cell carcinoma to photodynamic therapy by recruiting M1 macrophages.
Ji J; Wang P; Zhou Q; Zhu L; Zhang H; Zhang Y; Zheng Z; Bhatta AK; Zhang G; Wang X
Photodiagnosis Photodyn Ther; 2019 Jun; 26():235-243. PubMed ID: 30902794
[TBL] [Abstract][Full Text] [Related]
10. The effect of ALA-PDT on reversing the activation of cancer-associated fibroblasts in cutaneous squamous cell carcinoma.
Li S; Wang P; Zhang G; Ji J; Lv T; Wang X; Wang H
Photodiagnosis Photodyn Ther; 2019 Sep; 27():234-240. PubMed ID: 31163284
[TBL] [Abstract][Full Text] [Related]
11. Modified topical photodynamic therapy of superficial skin tumors, utilizing aminolevulinic acid, penetration enhancers, red light, and hyperthermia.
Harth Y; Hirshowitz B; Kaplan B
Dermatol Surg; 1998 Jul; 24(7):723-6. PubMed ID: 9693665
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of MAPK signaling pathways enhances cell death induced by 5-Aminolevulinic acid-photodynamic therapy in skin squamous carcinoma cells.
Ge X; Liu J; Shi Z; Jing L; Yu N; Zhang X; Jiao Y; Wang Y; Li PA
Eur J Dermatol; 2016 Apr; 26(2):164-72. PubMed ID: 27032574
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic therapy with topical methyl- and hexylaminolevulinate for prophylaxis and treatment of UV-induced SCC in hairless mice.
Togsverd-Bo K; Lerche CM; Poulsen T; Wulf HC; Haedersdal M
Exp Dermatol; 2010 Aug; 19(8):e166-72. PubMed ID: 20100196
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up and histological changes of superficial nonmelanoma skin cancers treated with topical delta-aminolevulinic acid photodynamic therapy.
Fink-Puches R; Soyer HP; Hofer A; Kerl H; Wolf P
Arch Dermatol; 1998 Jul; 134(7):821-6. PubMed ID: 9681345
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy using a novel photosensitizer, TONS501, is similarly effective to ALA and EC036 photodynamic therapy on DMBA-and TPA-induced mouse skin papilloma.
Takahashi H; Nakajima S; Asano R; Nakae Y; Sakata I; Iizuka H
J Dermatol Sci; 2012 Jun; 66(3):221-4. PubMed ID: 22464765
[TBL] [Abstract][Full Text] [Related]
16. Sequential Treatment of Superficial Basal Cell Carcinomas With Topical Methyl Aminolevulinate Photodynamic Therapy and Imiquimod 5% Cream: A Retrospective Study of Clinical and Cosmetic Outcomes.
Logan IT; Kulakov EL; Perrett CM
Dermatol Surg; 2020 Oct; 46(10):1272-1278. PubMed ID: 32011386
[TBL] [Abstract][Full Text] [Related]
17. A comparison of invasive squamous cell carcinoma greater than 1 year after treatment with 5-fluorouracil, imiquimod, or photodynamic therapy with aminolevulinic acid.
Cheng B; Veerabagu S; Miller CJ; Sobanko JF; Shin TM; Higgins HW; Giordano CN; Etzkorn JR
J Am Acad Dermatol; 2022 Sep; 87(3):592-596. PubMed ID: 35661760
[TBL] [Abstract][Full Text] [Related]
18. Halofuginone enhances the anti-tumor effect of ALA-PDT by suppressing NRF2 signaling in cSCC.
Lv T; Huang J; Wu M; Wang H; Zeng Q; Wang X
Photodiagnosis Photodyn Ther; 2022 Mar; 37():102572. PubMed ID: 34628069
[TBL] [Abstract][Full Text] [Related]
19. Photodynamic therapy as an alternative treatment in patients with invasive cutaneous SCC where surgery is not feasible: Single center experience.
Zhang GL; Keyal U; Shi L; Wang PR; Zhang LL; Bhatta AK; Wu YH; Fang S; Wang XL
Photodiagnosis Photodyn Ther; 2020 Dec; 32():101980. PubMed ID: 32866632
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2 is a possible target of treatment approach in conjunction with photodynamic therapy for various disorders in skin and oral cavity.
Akita Y; Kozaki K; Nakagawa A; Saito T; Ito S; Tamada Y; Fujiwara S; Nishikawa N; Uchida K; Yoshikawa K; Noguchi T; Miyaishi O; Shimozato K; Saga S; Matsumoto Y
Br J Dermatol; 2004 Aug; 151(2):472-80. PubMed ID: 15327557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
